Isolation, purification and characterization of novel antimicrobial compound 7-methoxy-2,2-dimethyl-4-octa-4′,6′-dienyl-2-napthalene-1-one from  sp. and its cytotoxicity studies by unknown
Kaur et al. AMB Expr  (2015) 5:40 
DOI 10.1186/s13568-015-0120-9
ORIGINAL ARTICLE
Isolation, purification and 
characterization of novel antimicrobial 
compound 7-methoxy-2,2-dimethyl-4-octa-4′, 
6′-dienyl-2H-napthalene-1-one from Penicillium 
sp. and its cytotoxicity studies
Harpreet Kaur1, Jemimah Gesare Onsare1, Vishal Sharma2 and Daljit Singh Arora1*
Abstract 
Fungus isolated from soil has been evaluated for its antimicrobial activity which showed broad spectrum antimi-
crobial activity against all the pathogenic microorganisms used. Optimization was done by response surface meth-
odology (RSM) to further optimize the medium which could further enhance the antimicrobial activity by 1.1–1.9 
folds. Column chromatography was used to isolate the active compound which was characterized to be by various 
spectroscopic techniques such NMR, IR and LCMS and it was found to be apparently novel compound 7-methoxy-
2,2-dimethyl-4-octa-4′,6′-dienyl-2H-napthalene-1-one. MIC of the active compound ranged from (0.5–15 µg/mL 
which was found to be comparable with the standard antibiotics. Viable cell count studies of the active compound 
showed it to be bactericidal in nature. Further, the compound when tested for its biosafety was found neither to be 
cytotoxic nor mutagenic. Cytotoxicity studies of the compound on cancer cell lines showed a valuable cytotoxic 
potential against all tested human cancer cell lines. Further, the compound induces apoptosis in lung cancer (A549) 
cells reveled by increase the distribution of nuclear DNA in Sub G1 phase as observed in flow cytometry. The study 
demonstrated that an apparently novel compound isolated from Penicillium sp. seems to be a stable and potent 
antimicrobial.
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Introduction
Microorganisms have been used as a source for the pro-
duction of variety of bioactive metabolites. These include 
bacteria, algae, fungi, actinomycetes etc. Numbers of 
bioactive metabolites have been isolated from these 
natural sources. The discovery and development of anti-
biotics was one of the most significant advances in the 
medicine in the 20th century. Till now many antibiotics 
have been commercialized to fight against various dis-
eases. The bacterial resistance is spreading throughout 
the world, revealing the steadily decreasing potencies of 
relevant antibiotics (Gould 2008) thus necessitating the 
discovery of novel compounds or modification of already 
existing antimicrobial stock. Now days, multiple drug-
resistant microorganisms such as methicillin-resistant 
Staphylococcus aureus (MRSA), vancomycin-resistant 
S. aureus (VRSA), vancomycin-resistant Enterococci 
(VRE), have increased around the world (Gould 2008). 
Extended spectrum β-lactamases (ESBLs) produc-
ing Escherichia coli, Klebsiella pneumoniae and Pseu-
domonas aeruginosa, are becoming resistant to almost 
every available antibiotic (Livermore 2009). Soil holds 
an enormous biodiversity that can be screened for anti-
biotic production. Because of huge expenditure on syn-
thetic molecules with effective antimicrobial properties, 
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natural products are still worth promise (Newman and 
Cragg 2007).
Filamentous fungi are widely distributed in the envi-
ronment. The wonder drug directed the interest of the 
researchers towards natural resources having different 
biological activities. Since then, a number of compounds 
with antibiotic activity have been isolated from different 
fungi such as, Penicillium janczewskii, Penicillium cane-
scens (Kozlovskii et  al. 1997), Penicillium sclerotiorium, 
Penicillium janthinellum, Penicillium citrinum (Taka-
hashi et al. 2008), Myrothecium cinctum (Kobayashi et al. 
2004) and Aspergillus fumigatus (Furtado et al. 2005), etc. 
Fungi are historically important sources of secondary 
metabolites and they continue to provide new chemical 
entities with novel biological activities (Baker and Alvi 
2004). They provide a rich source of compounds for ther-
apeutic applications including antibacterial (Takahashi 
et  al. 2008), antifungal (Nicoletti et  al. 2007), antiviral 
(Nishihara et al. 2000), immunosuppressant and choles-
terol-lowering agents (Kwon et al. 2002). Number of fungi 
showing differ rent biological activities have been listed 
in the literature; still a lot remains untapped from diverse 
soil habitats. Screening of novel strains is bringing about 
microorganisms, not yet assayed for their antibacterial 
activity that can yield innovative molecules or useful 
templates for development of new antibiotics (Takahashi 
et al. 2008). There is a wide variety of fungi used in the 
production of these compounds including Penicillium 
spp. which are also exploited to produce bioactive mol-
ecules such as antibiotics, enzymes, and organic acids. 
A large number of fungal extracts and or extracellular 
products have been found to possess antimicrobial activ-
ity, mainly from the filamentous fungi Penicillium (Petit 
et  al. 2009). Many Penicillium spp. have been screened 
for bioprocessing since the discovery of penicillin, still 
many of the species and strains remain untapped which 
may be useful for various pharmaceutical purposes. Tak-
ing cognizance of wide biological importance of Penicil-
lium spp., the present study was designed to isolate and 
screen the fungi from soil collected from different areas 
of Punjab (30° 4′ N, 75° 5′ E), India. One such promising 
isolate, Penicillium sp. showing antimicrobial activity was 




The reference strains of bacteria and yeasts were obtained 
from Microbial Type Culture Collection (MTCC), Insti-
tute of Microbial Technology (IMTECH), Chandi-
garh, India and the clinical isolate methicillin resistant 
Staphylococcus aureus (MRSA) was obtained from Post 
graduate Institute of Medical Education and Research 
(PGIMER), Chandigarh, India. Reference strains included 
Gram positive bacteria: Enterococcus faecalis (MTCC-
439), S. aureus (MTCC-740), Staphylococcus epidermidis 
(MTCC-435), Gram negative bacteria: E. coli (MTCC-
119), K. pneumoniae 1 (MTCC-109), K. pneumoniae 2 
(MTCC-530), P. aeruginosa (MTCC-741), Salmonella 
typhimurium 1 (MTCC-98), S. typhimurium 2 (MTCC-
1251), Shigella flexneri (MTCC-1457) and two yeast 
strains: Candida albicans (MTCC-227), and Candida 
tropicalis (MTCC-230).
Fungal isolation and extract preparation
Fungus was isolated as described earlier (Kaur et  al. 
2014) using yeast extract glucose agar (YGA) medium. 
Fifty millilitre YPDS medium (g/L) with pH-6, taken 
in 250  mL flasks, was inoculated with four fungal discs 
(8  mm) of 6–7  days old culture grown on YGA. After 
7  days of incubation at 25°C as stationary culture, the 
contents were filtered through Whatman filter paper no. 




A loopful of bacterial and yeast colonies were respectively 
inoculated into 5  mL of nutrient broth and yeast malt 
medium and incubated at 37 and 25°C, respectively for 
4  h. The turbidity of actively growing microbial suspen-
sion was adjusted to match the turbidity standard of 0.5 
Mc Farland units (Kaur and Arora 2009). The inoculum 
thus prepared was used to assay their sensitivity to fungal 
extract by agar well diffusion assay (Bauer et al. 1996).
Statistical optimization of the medium
On the basis of our previous results (Arora and Kaur 
2011) obtained from screening of different carbon and 
nitrogen sources through one-factor-at-a-time clas-
sical method; starch, dextrose and yeast extract were 
taken as independent variables for further optimiza-
tion by response surface methodology (RSM) using 
Box–Behnken design (Arora and Sharma 2011; Box and 
Behnken 1960). Each variable was studied at three levels 
(−1, 0, +1); for starch and dextrose these were 0.5, 1.25 
and 2%, while for yeast extract it was 0.4, 1.2 and 2%. The 
experimental design included 17 flasks with five repli-
cates having all the three variables at their central coded 
values. The mathematical relationship of response G (for 
each parameter) and independent variable X (X1, dex-
trose; X2, Starch; X3, Yeast extract) was calculated by the 
following quadratic model equation.







3 + β12X1X2 + β13X1X3 + β23X2X3
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where, G is the predicted response; β0 is intercepted; β1, 
β2 and β3 are linear coefficients; β11, β22 and β33 are 
squared coefficients and β12, β13 and β23 are interaction 
coefficients. MINITAΒ statistical software was used to 
obtain optimal working conditions and generate response 
surface graphs.
Isolation and purification of bioactive compound
For the extraction and purification of active group/
component from Pencillium sp., 3 L of the culture broth 
was extracted with equal volume of butanol (1:1). The 
organic layer was separated and treated with Na2SO4 
and then evaporated to dryness in vacuum and the 
resulting solids 4.5 g were subjected to column chroma-
tography using silica gel (100–200 mesh size, column 
18  mm  ×  300  mm; Hi-media) packed and pre-equili-
brated with hexane. The column was first eluted with 
equilibration solvent i.e. hexane (two bed volumes) fol-
lowed by linear gradients of hexane: chloroform (100:0, 
90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 
10:90, 0:100) at a flow rate of 1  mL/min followed by 
linear gradients of hexane: ethyl acetate (100:0, 90:10, 
80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, 
0:100). Different fractions of 20  mL each were col-
lected and after concentration were subjected to agar 
disc diffusion assay and thin layer chromatography. 
Hexane: chloroform (8:2) was used as screening system 
to develop the chromatograms which were observed 
under UV light (254 and 365 nm) and in iodine cham-
ber. Fractions which showed similar TLC pattern were 
pooled, concentrated and again loaded to silica gel 
(100–200 mesh size), column (10 mm × 300 mm) and 
pre-equilibrated with hexane (two bed volumes). The 
column after elution with hexane was eluted with lin-
ear gradients of Hexane: Chloroform (as above) and 
fraction size reduced to 5  mL. The collected fractions 
were tested for antimicrobial activity and thin layer 
chromatography. The single bands with similar Rf value 
were pooled and again checked for antimicrobial activ-
ity against S. aureus and C. albicans with disc diffusion 
assay. These pooled single bands were then loaded to 
HPLC and were further subjected to various spectro-
scopic analyses.
HPLC analysis
The purified active fractions as obtained above were fur-
ther subjected to high pressure liquid chromatography 
(HPLC) using Dionex P680 HPLC. Acetonitrile (75% 
aqueous solution) was used as mobile phase at a flow rate 
0.3 mL/min and injection volume was 20 µL at a column 
temperature of 25°C. The detections were monitored at 
different wavelengths (225, 250, 275 and 300 nm).
Spectroscopic analysis
The purified fraction from column chromatography was 
further subjected to various spectroscopic analyses for 
the characterization of the compound. Bruker AC-400 
FT (400 MHz) spectrometer was used to record 1H and 
13C nuclear magnetic resonance (NMR) spectra. Chemi-
cal shifts (δ) are reported as downfield displacements 
from trimethylsilane (TMS) used as internal standard 
and coupling constants are reported in Hz. Infrared (IR) 
spectra was recorded on Varian 660-IR Fourier Trans-
form Infra-Red Spectrometer in KBr pellets coated with 
chloroform film. A mass spectrum by EI and ESI meth-
ods was recorded on Bruker microTOF using ESI-TOF 
method.
Minimum inhibitory concentration (MIC)
Minimum inhibitory concentration of the butanolic 
extract as well as for the purified compound was worked 
out by agar dilution method (Kaur and Arora 2009). 
A stock solution of butanolic extract (25  mg/mL) and 
for purified compound (10  mg/mL) concentration was 
prepared and incorporated into Mueller–Hinton agar 
medium for bacteria and yeast malt extract medium 
for yeast. The final concentrations of the compound 
in the medium containing plates ranged from (0.1–20 
mg/mL) for butanolic extract and (0.5–15  µg/mL) for 
pure compound. The experiment was performed in dupli-
cate along with standard drugs (gentamicin 0.059 mg/mL 
and amphotericin B 0.75 mg/mL).
Time kill assay
A stock solution 25  mg/mL of butanolic extract of the 
fungus and for the purified compound stock solution 
of (10  mg/mL) was prepared and the time kill assay for 
butanolic extract and the purified compound was per-
formed by viable cell count method (VCC) (Kaur and 
Arora 2009).
Post antibiotic studies
The PAE of butanolic extract and the compound was 
studied as described by Raja et al. (2011). The extract was 
mixed with each test organism (in equal volume) con-
taining approximately 1 × 105 cfu/mL suspended in suit-
able broth medium. After 2 h exposure the drug activity 
was stopped by placing 1:1,000 dilution of microbial sus-
pension in a broth drug free pre-warmed suitable double 
strength broth. CFU sampling was done at an interval of 
1 h until visual cloudiness was noted. The PAE was cal-
culated as follows PAE = T − C, where T represents the 
time required for the count in the test culture to increase 
1log 10  cfu/mL above the count observed immediately 
after drug removal and C represents the time required 
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Butanolic extract and the purified compound were sub-
jected to both spot and plate incorporation methods of 
Ames test to evaluate their mutagenicity (Maron and 
Ames 1983). This Salmonella reverse mutation test is 
based on histidine dependence and mutations in S. typh-
imurium (MTCC-1251, IMTECH, Chandigarh, India). In 
case of plate method, 0.1  mL of the bacterial inoculum 
was added which was adjusted according to its MIC value 
and 0.1  mL of butanolic extract (25  mg/mL) as well as 
purified compound (10 mg/mL) to 5 mL of top agar con-
taining 0.25 mL of 0.5 mM histidine–biotin mixture (1:1 
ratio). The contents were mixed and poured onto glucose 
minimal agar plates immediately. Similarly, the same pro-
tocol was followed for spot method except that butanolic 
extract and the purified compound were impregnated 
on to disc which was placed in the centre of the plate. 
Sodium azide (5 μL of 17.2 mg/mL) was used as a posi-
tive control while DMSO was used as negative control. 
The plates were prepared in duplicate and incubated at 
37°C for 48  h. The number of visible revertant colonies 
was counted. The mutagenic potential of the extracts was 
determined on the basis of number of colonies as com-
pared to positive control.
Cellular toxicity testing using MTT assay
The cellular toxicity of butanolic extract and the purified 
compound was determined by MTT (3-[(4, 5-dimethyl-
thiazol-2-yl)-2, 5-diphenyl] tetrazolium bromide) assay 
(Ciapetti et al. 1993). Ten millilitre sheep blood was taken 
into injection syringe containing 3 mL Alsever’s solution 
(anticoagulant) and transferred to sterile centrifuge tubes. 
The blood was centrifuged at 1,600×g at room tempera-
ture (25 ± 3°C) for 20 min to separate the plasma from 
the cells. The supernatant was discarded and centrifuged 
again adding 6  mL phosphate buffer saline (PBS). The 
blood cells were washed thrice with PBS by centrifuga-
tion and the pellet was resuspended in 6 mL of PBS. Vari-
ous dilutions of these cells using PBS were prepared and 
counted with the help of a haemocytometer under a light 
microscope so as to obtain cells equivalent to 1  ×  105 
cells. The following formula was used to determine the 
required number of cells: number of cells/mL = number 
of cells counted in 25 squares  ×  dilution factor  ×  104. 
The cell suspension thus prepared was dispensed into 
Elisa plates (100 µL/well) and incubated at 37°C for over-
night. The supernatant was removed carefully and 200 µL 
of the extract and the purified compound was added and 
incubated further for 24  h. Supernatant was removed 
again and added 20  µL MTT solutions (5  mg/mL) to 
each well and incubated further for 3 h at 37°C on orbital 
shaker at 60 rpm. After incubation, the supernatant was 
removed without disturbing the cells and 50  µL DMSO 
was added to each well to dissolve the formazan crystals. 
The absorbance was measured at 590 nm using an auto-
mated microplate reader (Biorad 680-XR, Japan). The 
wells with untreated cells served as control.
Cytotoxic activity
The sulforhodamine B (SRB) assay is a colorimetric assay 
used for cytotoxic screening to assess cell growth inhibi-
tion (Skehan et al. 1990). Cells are cultured in a 96 well 
tissue culture plate and the cell growth which depends 
upon the rate of multiplication is measured indirectly 
by the intensity of the color of the dye which is directly 
proportional to the number of cells present. The human 
cancer cell lines (procured from N.C.I., Frederick, USA) 
were grown in tissue culture flasks in complete growth 
medium (RPMI-1640 with 2 mM glutamine, pH 7.4, sup-
plemented with 10% fetal calf serum, 100 µg/mL strepto-
mycin and 100 units/mL penicillin) in a carbon dioxide 
incubator (37°C, 5% CO2, 90% RH). The cells at sub-con-
fluent stage were harvested from the flask by treatment 
with trypsin [0.05% in PBS (pH 7.4) containing 0.02% 
EDTA]. Cells with viability of more than 98% as deter-
mined by trypan blue exclusion were used. For deter-
mination of cytotoxicity the cell suspension of 1  ×  105 
cells/mL was prepared in complete growth medium. 
Stock solution of the purified compound was prepared in 
DMSO and it was serially diluted with complete growth 
medium containing 50  µg/mL of gentamicin to obtain 
working test solutions of required concentrations. In 
vitro cytotoxicity against five human cancer cell lines 
of different tissues was determined using 96-well tissue 
culture plates. The 100 µL of cell suspension was added 
to each well of the 96-well tissue culture plate. The cells 
were allowed to grow in carbon dioxide incubator (37°C, 
5% CO2, 90% RH) for 24  h. Test materials in complete 
growth medium (100 µL) were added after 24 h of incu-
bation to the wells containing cell suspension. The plates 
were further incubated for 48 h in a carbon dioxide incu-
bator. The cell growth was stopped by gently layering 
trichloroacetic acid (50%, 50  µL) on top of the medium 
in all the wells. The plates were incubated at 4°C for 1 h to 
fix the cells attached to the bottom of the wells. The liq-
uid of all the wells was gently pipette out and discarded. 
The plates were washed five times with distilled water to 
remove trichloroacetic acid, growth medium, low molec-
ular weight metabolites, serum proteins etc. The plates 
were stained with sulforhodamine B dye [0.4% (w/v) in 
1% acetic acid (v/v), 100 µL] for 30 min. The plates were 
washed five times with 1% acetic acid and then air-dried 
Page 5 of 13Kaur et al. AMB Expr  (2015) 5:40 
(Skehan et al. 1990). The adsorbed dye was dissolved in 
Tris–HCl buffer (100  µL, 0.01  M, pH 10.4) and plates 
were gently stirred for 10  min on a mechanical stirrer. 
The optical density (OD) was recorded on ELISA reader 
at 540 nm. The cell growth was determined by subtract-
ing mean OD value of respective blank from the mean 
OD value of experimental set. Considering the growth in 
the absence of any test material as 100%, percent growth 
inhibition was calculated. IC50 values were determined by 
non-linear regression analysis using Graph Pad Software 
(2236 Avenida de l Playa La Jolla, CA 92037, USA).
Flow cytometry analysis of nuclear DNA
Analysis of nuclear DNA by flow cytometry is interesting 
in fundamental research and has broadly contributed to 
improved knowledge on cell DNA content and their dis-
tribution in the various phases of cell cycle. DNA amount 
in cells is often the single parameter measured for cell 
cycle studies by flow cytometry. In order to obtain a lin-
ear relationship between cellular fluorescence intensity 
and DNA amount, analyses are performed with fluores-
cent molecules that bind specifically and stoichiometri-
cally to DNA. Some dyes possess an intercalative binding 
mode such as propidium iodide etc., whereas others such 
as Hoechst 33342, DAPI etc. possess an affinity for DNA 
A-T rich region. To analyze the nuclear DNA content, 
lung cancer cells (2  ×  106 cells/mL/well) were treated 
with purified compound for 24  h at concentrations 10 
and 20  µM, and washed twice with ice-cold PBS, har-
vested, fixed in cold 70% ethanol in PBS and stored at 
−20°C for 30 min. After fixation, the cells were incubated 
with RNase A (0.1  mg/mL) at 37°C for 30  min, stained 
with propidium iodide (50  µg/mL) for 30  min and then 
measured for nuclear DNA content using BD-LSR Flow-
cytometer (Becton–Dickinson, USA) equipped with 
electronic doublet discrimination capability using blue 
(488 nm) excitation from argon laser.
Statistical analysis
The values have been presented as mean of three inde-
pendent experiments. Single factor analysis of variance 
(ANOVA) was used to calculate the significant difference.
Results
Antimicrobial screening
The isolated fungus was identified as Penicillium sp. close 
to P. citrinum group by National Fungal Culture Col-
lection of India (NFCCI), Agharkar Research Institute, 
Pune, India (Accession No. NFCCI 2555) Extracellu-
lar culture broth of the selected fungus. It showed anti-
microbial activity against two Gram positive bacteria: 
S. aureus (34  mm) S. epidermidis (36  mm) and MRSA 
(17 mm), one Gram negative bacteria: K. pneumoniae 1 
(17  mm) and one yeast C. albicans (18  mm),while rest 
of the organisms were found to be resistant to extracel-
lular culture broth. Further, to enhance the antimicrobial 
activity, RSM experiment was designed using the carbon 
and nitrogen sources.
Box–Behnken design for statistical optimization of 
carbon and nitrogen sources for antimicrobial activity of 
Penicillium sp.
On the basis of results obtained from screening of dif-
ferent carbon and nitrogen sources through one-factor-
at-a-time classical method; these were optimized by RSM 
using Box–Behnken design of experiments
•  S. aureus (G1)
Linear effect of starch and squared effect of dextrose 
was highly significant with P value ≤0.001. Similarly lin-
ear effect of yeast extract and squared effect of starch 
was significant with P value ≤0.05 and R2 value of 94.4%. 
The response surface graph showed the highest activity 
at 2% starch, 1–1.5% dextrose, with yeast extract 0.2% 
(Figure 1a).
•  S. epidermidis (G2)
Linear effect of starch and squared effect of dextrose 
was highly significant with P value ≤0.001. Similarly 
linear effect of yeast extract was found to be significant 
with P value ≤0.05. Interactive effect of starch and yeast 
extract was also found to be significant P value ≤0.05 and 
R2 value observed was 92.7%. The response surface graph 
showed the highest activity at 1–1.5% dextrose, starch 2% 
and yeast extract 0.2% (Figure 1b).
•  K. pneumoniae 1 (G3)
Linear effect of starch was highly significant with P 
value ≤0.001. Linear effect of dextrose and squared effect 
of starch was also significant with P value ≤0.05. Interac-
tive effect of starch and yeast extract, starch and dextrose 
was significant with P value ≤0.05. R2 value observed was 
91.3%. The response surface graph showed the highest 
activity at starch 2%, dextrose 1.5–2% and yeast extract 
0.2% (Figure 1c).
32.4 + 6.87 X1 + 1.25 X2 − 2.1 X3 − 3.0 X
2





3 + 0.5 X1X2 − 2.75 X1X3 + 2.0 X2X3
32.2+ 7.25 X1 + 0.5 X2 − 2.5 X3 − 1.1 X
2





3 + 2 X1X2 − 3.5 X1X3 + 1.0 X2X3
6.2+ 4.1 X1 + 1.87 X2 − 1.25 X3 + 3.15 X
2





3 + 3.0 X1X2 − 3.25 X1X3 − 0.25 X2X3
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•  MRSA (G5)
Linear effect of starch was highly significant with P 
value ≤0.005. Squared effect of starch and interactive 
effect starch and yeast extract was significant with P value 
≤0.05 and R2 value of 87.1%. The response surface graph 
showed the highest antimicrobial activity at dextrose 
1.5–2%, starch 2% and yeast extract 0.2% (Figure 1d).
16.4 + 3.25 X1 + 1.75 X2 − 1 X3 + 3.4 X
2





3 + 1.75 X1X2 − 3.25 X1X3 − 0.25 X2X3
•  C. albicans
Linear effect of starch was highly significant with P 
value ≤0.005. Linear effect of dextrose and squared effect 
of starch was significant with P value ≤0.05. Interactive 
effect of starch and dextrose; starch and yeast extract was 
significant with P value ≤0.05 and R2 value of 90.8%. The 
response surface graph showed the highest antimicrobial 
17.4 + 4.12 X1 + 2.12 X2 − 2.0 X3 + 3.92 X
2





3 + 3.75 X1X2 − 4.5 X1X3 − 0 X2X3
Figure 1 a Contour plot of Staphylococcus aureus. b Contour plot of Staphylococcus epidermidis. c Contour plot of Klebsiella pneumoniae 1. d Con-
tour plot of MRSA. e Contour plot of C. albicans.
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activity at dextrose 1.5–2%, starch 2% and yeast extract 
0.2% (Figure 1e).
Validation of results
Thus from the overall assessment 2% starch, dextrose 
1–2%, yeast extract 0.2% and 1% peptone in YPDS medium 
may be regarded as the optimized conditions for antimi-
crobial activity. The F value and R2 value showed that the 
model correlated well with measured data and was statis-
tically significant. To confirm the adequacy of the model 
the verification experiments using optimum medium com-
position as described above were carried out in triplicates. 
The antimicrobial activity (Table  1) was enhanced by 1.1 
folds in S. aureus and S. epidermidis. However, an increase 
of 1.8 fold was observed for K. pneumoniae1 and MRSA 
while in C. albicans, it increased by 1.9 folds.
Isolation and purification of bioactive compound
For the extraction and purification of active group/com-
ponent from Penicillium sp., three liters of the culture 
broth was extracted with equal volume of butanol (1:1). 
All the fractions (120) obtained from column chroma-
tography were pooled according to similar pattern of 
chromatogram on TLC plates. Three sets of fractions (A, 
B and C) were obtained from column chromatography 
having similar Rf value and antimicrobial activity against 
various pathogenic bacteria and yeast strains such as S. 
aureus, S. epidermidis, K. pneumoniae 1, MRSA, C. albi-
cans, S. typhimurium 1, S. typhimurium 2, Sh. flexneri 
and E. coli. The second set (B) of pooled fraction showed 
a single spot on TLC with Rf value (0.65 cm). It was fur-
ther subjected to HPLC analysis to determine the purity 
of active compound which showed single peak at reten-
tion time 8.643 min. However, Set A and C also showed 
antimicrobial activity but had some impurities. First set 
(A) showed antimicrobial activity with zone of inhibi-
tion ranging from 20 to 23  mm followed by second set 
(B) which showed zone of inhibition ranging from 17 to 
20 mm against various microbial strains. As the second 
set (B) showed single spot on TLC, it was pursued for 
further spectroscopic analysis. The compound responsi-
ble for antimicrobial activity was characterized by vari-
ous spectroscopic techniques such as IR, 1H & 13C NMR 
and mass. Colour of compound: Yellowish brown: IR 
(KBr, CHCl3): λmax  =  2,940, 2,915, 2,876, 1,666, 1,651, 
1,535, 1,454, 1,373, 1,284, 1,161, 1,107, 1,072, 968, 
756  cm−1; 1H NMR (400  MHz, CDCl3): δ 9.35 (s, 1H, 
C8-H), 8.26–8.12 (d, 1H, J = 8.0 Hz C5-H), 7.61 (d, 1H, 
J =  8.0  Hz, C6-H), 7.39–7.20 (m, 2H, C4′-H & C6′-H), 
6.91–6.84 (m, 3H, C5′-H, C7′-H & C3-H), 4.37 (s, 3H, 
OCH3), 2.04 (t, 2H, J = 5.2 Hz, C1′-H), 1.92–1.87 (m, 2H, 
C2′-H), 1.40–1.24 (m, 2H, C3′-H), 1.11 (s, 6H, 2 × CH3); 
13C NMR (100  MHz, CDCl3): δ 170.2 (C=O), 169.1 
(olefinic CH), 166.4 (arom. q), 163.7 (olefinic CH), 160.1 
(arom. q), 147.9 (C4), 125.6 (olefinic CH), 124.5 (olefinic 
CH), 121.9 (olefinic CH), 118.8 (arom. CH), 116.2 (arom. 
CH), 67.0 (OCH3), 57.2 (q), 45.8 (CH2), 44.5 (CH2), 
27.8 (CH2), 21.9 (CH3), 19.1 (CH3); HR-MS (TOF, ESI): 
m/z: calculated for C21H26O2  +  [Na]: 333.1803; found: 
333.1766 [M + Na]+ (Additional file 1: Figure S1).
Table 1 Result of Box–Benhken design experiment for antimicrobial activity of Penicillium sp
Std. Dextrose Starch Yeast extract S. aureus S. epidermidis K. pneumoniae C. albicans MRSA
(g/100 mL) Zone of inhibition (mm)
1 0.5 0.5 0.5 15 17 14 17 15
2 0.5 2 0.5 27 28 16 17 18
3 2 0.5 0.5 20 17 14 17 17
4 2 2 0.5 34 36 28 32 27
5 1.25 0.5 0.2 20 20 15 16 17
6 1.25 2 0.2 40 41 30 34 30
7 1.25 0.5 0.8 21 25 16 18 18
8 1.25 2 0.8 30 32 18 18 18
9 0.5 1.25 0.2 30 30 14 17 15
10 2 1.25 0.2 25 26 16 18 17
11 0.5 1.25 0.8 22 20 15 16 17
12 2 1.25 0.8 25 20 16 17 18
13 1.25 1.25 0.5 33 34 16 17 16
14 1.25 1.25 0.5 30 28 17 17 17
15 1.25 1.25 0.5 32 33 16 18 17
16 1.25 1.25 0.5 35 33 16 18 16
17 1.25 1.25 0.5 32 33 16 17 16
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Minimum inhibitory concentration (MIC)
Equal volume of the culture broth from Penicillium sp. 
was extracted with equal volume of butanol in separat-
ing funnel. The organic phase was separated and the sol-
vent was then evaporated to dryness under vacuum and 
the residue obtained was reconstituted in dimethyl sul-
foxide (DMSO). Minimum inhibitory concentration was 
worked out for butanolic extract of the fungus as well 
as for the purified compound by agar dilution method 
(Table  2). Butanolic extract showed significant antimi-
crobial activity with MIC 0.1  mg/mL against S. aureus, 
and K. pneumoniae 1, followed by MIC 0.2  mg/mL for 
S. epidermidis and C. albicans, against MRSA, 0.7  mg/
mL, S. typhimurium 2 and P. aeruginosa 1  mg/mL. The 
butanolic extract also showed good inhibitory activ-
ity against Sh. flexneri and E. faecalis with MIC 5  mg/
mL, followed by MIC value of 10 mg/mL and 20 mg/mL 
against S. typhimurium 1 and K. pneumoniae 2, respec-
tively. MIC of purified compound against C. albicans and 
K. pneumoniae 1 with 1 µg/mL as compared to standard 
antibiotics, amphotericin B (99  µg/mL) and gentamicin 
(1  µg/mL). It was followed by MIC 2  µg/mL against S. 
aureus and S. epidermidis whereas against MRSA 5  µg/
mL and S. typhimurium showed highest MIC (10 µg/mL).
Time kill assay
Time kill assay of butanolic extract and purified compound 
of Penicillium sp.
On the basis of 1× MIC, viable cell count studies were 
carried out. A stock solution 25  mg/mL of butanolic 
extract of Penicillium sp. and 10  mg/mL for purified 
compound respectively was prepared. Complete killing of 
E. coli was observed at 0 h of incubation. K. pneumoniae 
1 and C. albicans got completely killed at 2 h. E. faecalis 
took 4 h for complete killing, MRSA 6 h, S. epidermidis 
and P. aeruginosa got completely killed at 8 h whereas S. 
aureus and Sh. flexneri were killed at 10 h of incubation. 
S. typhimurium 1 took 14 h for complete inhibition and 
K. pneumoniae 2 took the longest time of 24 h for com-
plete killing (Figure 2).
Time kill assay using purified compound was also stud-
ied by viable cell count method. Among the tested organ-
ism, complete killing of E. coli and K. pneumoniae 1 was 
observed at 0 h. C. albicans got killed at 2 h of incubation, 
whereas MRSA and S. typhimurium 2 took 4 h whereas 
S. epidermidis took 6 h of incubation. S. aureus took the 
longest time and killed at 10 h of incubation (Figure 3).
Post antibiotic effect (PAE)
PAE is persistent suppression of bacterial growth after 
their brief exposure (1 or 2 h) to an antimicrobial agent 
even in the absence of host defense mechanisms. The 
concentrations used in kill time assay were applied in 
PAE studies. Butanolic extract of Penicillium sp. and the 
purified compound induced a varied PAE amongst test 
organisms and was concentration dependent. Butanolic 
extract of Penicillium sp. induce PAE ranging from 2 to 
20  h in the microorganisms tested. Sh. flexneri 2  h, S. 
aureus 4 h, S. epidermidis 4 h, MRSA 6 h, K. pneumoniae 
1 6 h, S. typhimurium 2 6 h, C. albicans 8 h and E. coli 
20 h, Similarly, purified compound induced PAE ranging 
from 4 h to 22 h. S. epidermidis 4 h, S. typhimurium 2 6 h, 
S. aureus 8 h, MRSA 10 h, C. albicans 12 h, K. pneumo-
niae 1 20 h, and E. coli 22 h (Figure 4).
Toxicity testing
To work out the biosafety of the butanolic extract and 
purified compound they were subjected to Ames muta-
genicity test and MTT cytotoxicity assay. While per-
forming the Ames test the number of revertant colonies 
Table 2 Comparison of MIC of butanolic extract and pure compound with two standard antibiotics
The values represents mean of three values, different lower case letters (a–c) show statistical significant (P ≤ 0.05) difference between columns.
Microorganisms MIC butanolic extract MIC of compound MIC of gentamicin MIC of amphotericin B
S. aureus 0.1c 2b 1a ND
S. epidermidis 0.2c 2b 1a ND
K. penumoniae 1 0.1c 1b 0.19a ND
C. albicans 0.2b 1a ND ND
MRSA 0.5c 5b 0.19a 99d
P. aeruginosa 1b ND 10a ND
S. typhimurium 2 0.7c 5b 2a ND
Sh. flexneri 5b ND 2a ND
E. faecalis 5b ND 10a ND
E. coli 10b ND 1a ND
S. typhimurium 1 15b ND 1a ND
K. penumoniae 2 20b ND 1a ND
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in the positive control was numerous, whereas the bac-
teria incubated with the butanolic extract and the puri-
fied compound did not show any revertant colonies. The 
glucose minimal agar media plates layered with top agar 
containing excess of biotin and no histidine also served as 
control as no colonies were observed.
In MTT assay, since the reduction of 3-[(4, 5-dimeth-
ylthiazol-2-yl)-2, 5-diphenyl] tetrazolium bromide 
(MTT) can only occur in metabolically active cells, as 
the mitochondrial succinate dehydrogenase enzymes in 
living cells reduce the yellow colored water soluble sub-
strate MTT into an insoluble, formazan crystals which 
are then dissolved in DMSO and the absorbance of 
purple colored solutions directly represents the viabil-
ity of the cells. In the present studies, 90 and 92% of the 
viable cells were observed in the butanolic extract and 
the purified compound respectively, showing both to be 
noncytotoxic.
Cytotoxic activity against human cancer cell lines
In the present study, purified compound was tested 
for its cytotoxicity against human cancer cell lines. The 
compound was found to be endowed with valuable cyto-
toxic potential against all tested human cancer cell lines 
(Table  3). The purified compound was found to display 
promising cytotoxicity with IC50 =  28 against leukemia 
cancer cell line (THP-1). Similarly, against prostate can-
cer cell line (PC-3), considerable inhibitory activity with 
(IC50  =  31) of the compound was observed. While for 
breast cancer cell line (MCF-7) the IC50 observed was 35 
and for lung cancer cell line (A549), +the compound dis-
played IC50 > 50.
Flow cytometery analysis of nuclear DNA
Morphological change is a primary indication of cell 
apoptosis. One of the specific characteristics of cell apop-
tosis is DNA fragmentation, which leads to the appear-
ance of hypodiploid cells. The cell cycle is a key factor in 
unregulated cell proliferation leading to cancer and dif-
ferential sensitivity to apoptosis is linked to the distinct 
phases of cell cycle (Pucci et al. 2000). The hypo diploid 
sub-G1 DNA fraction (<2n DNA) was found to increase 
from 37 to 58% for compound in a concentration depend-
ent manner (Figures  5, 6). In contrast to camptothecin 
(positive control) showed 48% hypo diploid DNA content 
at a concentration of 2 µM.
Figure 2 Time kill studies of butanolic extract of Penicillium sp.
Figure 3 Time kill studies of purified compound.
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These results indicate the capability of the purified 
compound to induce apoptosis in lung cancer (A549) 
cells.
Discussion
The emerging problem of increasing resistance led the 
researchers to look for the novel sources for antimicrobial 
agents or novel compounds from the existing sources. 
Penicillium spp. have been well known for their bioactive 
compounds with wide variety of biological activities. A 
number of Penicillium spp. have been studied but a lot 
more still remain untapped. Penicillium sp. in this study 
has been evaluated for its antimicrobial potential and fur-
ther the active compound has been purified. Even small 
changes in the culture medium may not only impact 
the quantity of certain compounds but also the general 
metabolic profile of microorganisms. The application of 
statistical experimental design techniques in the fermen-
tation process development can thus result in improve-
ment of product yield and reduce process variability.
The statistical optimization of various nutritional 
parameters by RSM resulted in 1.1–1.9 folds enhance-
ment in antimicrobial activity. A good agreement 
between the predicted and experimental results verified 
the validity of the model and the improvement of antimi-
crobial activity indicated the RSM to be a powerful tool 
for determining the exact optimal values of the individual 
factors and the maximum response value. Our results 
corroborate well with other studies where the activity 
was also enhanced by 1.1–1.8 folds (Wang et  al. 2011; 
Zhengyan et al. 2012).
The purified compound is apparently novel compound 
with broad spectrum antimicrobial activity. The structure 
Figure 4 Post antibiotic effect of the butanolic extract and pure compound.
Table 3 Percentage growth inhibition against  different 
cancer cell lines
Compounds Conc (µg/mL) A549 THP-1 PC-3 Colo-205
Lung Leukemia Prostate Colon
KB14 1 25 0 10 0
5 28 10 27 20
10 31 22 38 39
30 55 39 45 50
50 75 65 70 72
IC50 28 >50 31 35
5-FU 1 72 74 – –
Adriamycin 1 67 70 – 80
Mitomycin-c 1 – 67 71 – Figure 5 Overview of flowcytometric analysis of nuclear DNA.
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is elucidated on the basis of spectroscopic techniques. 
Proton NMR of the compound showed a signal of C8-H 
appeared as singlet at δ 9.35 downfield due to aniso-
tropic effect and hydrogen bonding with nearing car-
bonyl group. The aliphatic multiplet was also observed in 
the region of δ 1.92–1.87 and δ 1.40–1.24. The 13C NMR 
spectrum showed aromatic and olefinic carbon reso-
nances in the region of δ 169.1–166.4. The signals of ali-
phatic carbons appeared at the region of δ 57.2–15.1 and 
signal of carbonyl group appeared at δ 170.2, which fur-
ther analyzed by stretching appeared in IR spectrum at 
1,666 cm−1. The structure of compound was further cor-
roborated by mass spectrum which showed a molecular 
ion peak at m/z 333.1766 [M +  Na] +. On the basis of 
these observations the purified compound is proposed to 
be 7-methoxy-2,2-dimethyl-4-octa-4′,6′-dienyl-2H-
napthalene-1-one (Figure 7).
MIC of butanolic extract of the fungi ranged from 
(0.1–20  mg/mL) which supported the data obtained by 
agar well diffusion assay. The importance of the study was 
further highlighted where the purified compound showed 
better or equal activity when compared with standard 
antibiotics. MIC of amphotericin B against C. albicans 
was found to be 99  µg/mL whereas, purified compound 
was effective at much lower MIC of 1 µg/mL. The study 
showed its further importance when MRSA showed sen-
sitivity to the purified compound with MIC of 5  µg/mL 
Similarly, compound showed significant inhibitory poten-
tial against K. pneumoniae 1 with MIC 1 µg/mL which is 
Figure 6 Flow cytometric analysis of nuclear DNA treated compound and the standard.
Figure 7 7-Methoxy-2,2-dimethyl-4-octa-4′,6′-dienyl-2H-
napthalene-1-one.
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comparable with the gentamicin having MIC of 1 µg/mL. 
S. aureus also showed MIC of 2  µg/mL, S. epidermidis, 
2  µg/mL. The kill kinetics provides the more accurate 
description of antimicrobial agents than does the MIC 
(Mandal et  al. 2009). Time kill studies not only give the 
information about the nature of the antimicrobial agent 
whether the particular agent is bactericidal or bacterio-
static but also the time taken by the antimicrobial agent 
for complete killing of the microorganism. Viable cell 
count studies which showed the effectiveness of the com-
pound with complete killing of E. coli, and K. pneumoniae 
1 at 0  h and our observations are better than previous 
viable cell count studies with medicinal plants (Kaur and 
Arora 2009). The viable cell count studies thus endorse 
that the compound is having potent bactericidal activity.
The design of antimicrobial dosing regimens is mainly 
based on the susceptibility of pathogen and pharmacoki-
netic parameters such as drug concentration in serum 
and tissue. PAE is being applied increasingly to allow 
antimicrobial dosing regimens to be developed in a more 
scientific manner. Different antimicrobials induce varied 
duration of PAE against different types of microbes. The 
purified compound was found to be effective even after 
removing it and showed the PAE ranging from 4 to 22 h. 
More prolonged intermittent dosing regimens would 
apply primarily to antimicrobials that exhibit a prolonged 
PAE. On the other hand more continuous dosing would 
be necessary for antimicrobials that exhibit a shorter PAE 
or lack of PAE (Lorian 1996).
Further the isolated compound did not show any cyto-
toxicity as done by MTT assay and mutagenicity by Ames 
test indicating its suitability to proceed for further phar-
macological use.
Many compounds showing biological activities have also 
been listed in the literature from Penicillium sp. having 
no mutagenicity and cytotoxicity (Kaur et al. 2014; Arora 
and Chandra 2011). Cancer is a multifaceted and multi-
mechanistic disease, which is one of the leading causes 
of death. Beside surgical and other interventions, chemo-
therapy remains the mainstay of treatment of cancer (Har-
rison et al. 2009). The importance of this study was further 
highlighted when the compound was found to be endowed 
with valuable cytotoxic potential against all tested human 
cancer cell lines. Further the compound induces apoptosis 
in lung cancer (A549) cells as observed by flow cytometry.
This study conclude that the antimicrobial activity of 
the purified compound was found to be comparable with 
standard drugs. Moreover the compound was found to 
be noncytotoxic which will facilitate the further studies 
to gain better understanding of the production of bioac-
tive metabolites from fungi. Further, the compound also 
showed promising anticancerous activity which could be 
further use for various pharmaceutical purposes.
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